Analysts believe that while the deal is positive, Cipla's share price is unlikely to see a fresh run-up, given the rise it ...
India Today on MSN
Maker of blockbuster weight-loss drug Mounjaro ties up with Cipla to reach small-town India
US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...
Shares of Cipla fell more than 3 per cent on Friday after the drugmaker announced a partnership with US pharmaceutical major ...
Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting ...
Cipla has partnered with Eli Lilly and Company (India) to distribute & promote Tirzepatide in India under a second brand name, Yurpeak, aiming to expand access to innovative treatments for chronic ...
In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...
Weight loss medications can be lifesaving for people who need them — but there are errors you’ll want to avoid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback